`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BIB DATA SHEET
`
`Page 1 of 1
`
`UNITED STATES DEPARTNEENT OF CONHVIERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`CONFIRMATION NO. 1091
`
`SERIAL NUMBER
`14/500,409
`
`FILINS‘AQI'IE 371(6)
`09/29/2014
`
`GROUP ART UNIT ATTORNEg DOCKET
`1861 .2700001/JMC/MS I
`
`APPLICANTS
`
`RULE
`
`EURO-CELTIQUE S.A., Luxembourg, LUXEMBOURG, Assignee (with 37 CFR 1.172 Interest);
`INVENTORS
`
`Alexander OKSCHE, Limburg, GERMANY;
`William HEATH, Cambridge, UNITED KINGDOM;
`Timothy HOLDEN, Cambridge, UNITED KINGDOM;
`Derek A. PRATER, Cambridge, UNITED KINGDOM;
`Richard S. SACKLER, Greenwich, CT;
`Malcolm WALDEN, Cambridge, UNITED KINGDOM;
`** CONTINUING DATA *************************
`
`This application is a CON of 12/439,410 11/09/2009
`which is a 371 of PCT/EP2007/058978 08/29/2007
`
`** FOREIGN APPLICATIONS *************************
`
`EUROPEAN PATENT OFFICE (EPO) 061198396 08/30/2006
`
`** |F REQUIRED, FOREIGN FILING LICENSE GRANTED **
`10/09/2014
`
`
`
`BYeSZINo
`ForeignPriorichaimed
`
`35 USC 119(a—d) conditions met BYes :I No
`Verified and
`/CRA|G D RICCI/
`Acknowledged
`Examiner's Signature
`
`ADDRESS
`
`Allowance
`D Met after
`
`STATE OR
`COUNTRY
`
`SHEETS
`DRAWINGS
`
`TOTAL
`CLAIMS
`
`INDEPENDENT
`CLAIMS
`
`nitias
`
`GERMANY
`
`0
`
`24
`
`2
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 NEW YORK AVENUE, N.W.
`WASHINGTON, DC 20005
`UNITED STATES
`
`Buprenorphine-Wafer for Drug Substitution Therapy
`
`FEES: Authority has been given in Paper
`FILING FEE
`RECEIVED No.
`to charge/credit DEPOSIT ACCOUNT
`for following:
`
`II All Fees
`
`31.16 Fees (Filing)
`
`-
`-
`3 1-17 Fees (Process'ng EXt- 0“ “me
`:l 1.18 Fees (Issue)
`
`:l Other
`
`:l Credit
`
`
`
`BIB (Rev. 05/07).
`
`